BlueLinx Turns to Q3 2026 Net Loss of $625,000
Bitget2026/11/03 21:17- BlueLinx swung to a third-quarter 2026 net loss of $625,000 from net income of $1.66 million a year earlier.
- Net sales rose 9% year over year to $812.61 million, with growth across specialty and structural products.
- Gross profit climbed 21% year over year to $130.96 million, while gross margin reached 16.1%.
- Fourth-quarter 2026 gross margin is expected at 17.5%–18.5% for specialty products and 9%–10% for structural products.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
